Search results
Sarcoidosis has no known etiology, but it is very treatable. Understanding its management enables nurses to meet the challenges of patient care, conduct comprehensive assessments, provide compassionate care, advocate for their patients, and educate the public about sarcoidosis. REFERENCES
The diagnosis of sarcoidosis is not standardized but is based on the following three major criteria: a compatible clinical presentation (Table 1), the finding of nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternative causes of granulomatous disease (Table 2).
29 lis 2022 · Sarcoidosis is a heterogeneous disease with variable organ involvement, disease course, and response to treatment. We offer an angle on when and how to treat, and provide an overall roadmap for managing sarcoidosis.
8 wrz 2021 · Treatment guidelines for sarcoidosis are evolving, and health care providers are advised to consider a personalized approach based on individual variations in disease manifestations (Tables S1...
16 gru 2021 · The presented treatment guidelines aim to provide guidance to physicians treating the very heterogenous sarcoidosis manifestations.
26 cze 2024 · Cardiac sarcoidosis (CS) is a form of inflammatory cardiomyopathy associated with significant clinical complications such as high-degree atrioventricular block, ventricular tachycardia, and heart failure as well as sudden cardiac death.
The purpose of this clinical practice guideline is to make recommendations that address uncertainties that are commonly confronted by clinicians relating to the diagnosis and detection of sarcoidosis.
